Hepatitis B surface antigen chemiluminiscence immune detection reagent kit and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUZHOU HYBIOME BIOMEDICAL ENG CO LTD
- Publication Date
- 2018-07-31
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a hepatitis B surface antigen chemiluminescence immunoassay kit and application thereof, belonging to the technical field of in vitro detection. Background technique
[0002] Hepatitis B surface antigen (HBsAg) is the first serological marker to appear after hepatitis B virus (HBV) infection. The HBV replication cycle is fast and the polymerase is prone to mismatch, and the hepatitis B vaccine and antiviral therapy are widely used. HBsAg mutations are very common in patients with chronic HBV infection. HBsAg mutations can lead to negative HBsAg test results in patients, but HBV DNA still exists in their serum or liver, that is, occult HBV infection (OBI). If OBI patients are used as blood donors or liver transplant donors, they will pose a major risk to the safety of blood transfusion and surgery. At the same time, HBsAg mutation will accelerate the progression of occult hepatitis B to cirrhosis or liver cancer, and trigger H...